Work

Novel TGF-βinhibitors ready for prime time in onco-immunology

Year: 2016
Type: article
Abstract: Transforming Growth Factor (TGF)-β inhibitors have been in development for decades with the outmost results of being promising candidates. From the latest clinical results at the 2016 ASCO meeting converging evidences suggest that we have moved from promising to effective drug nominees.
Language: English
Open Access status: gold
Estimated APC paid: $2,913
OpenAlex ID: W2559766398
FWCI: 8.421
Cites: 12
Cited by: 204
Related to: 10